Growing community of inventors

New City, NY, United States of America

Eric C Ehrnsperger

Average Co-Inventor Count = 5.37

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Eric C EhrnspergerSyed Muzafar Shah (12 patents)Eric C EhrnspergerChristopher Richard Diorio (10 patents)Eric C EhrnspergerJonathan Marc Cohen (6 patents)Eric C EhrnspergerKadum A Al Shareffi (6 patents)Eric C EhrnspergerXu Meng (6 patents)Eric C EhrnspergerMahdi Bakir Fawzi (5 patents)Eric C EhrnspergerKadum A Ali (4 patents)Eric C EhrnspergerPanolil C Raveendranath (2 patents)Eric C EhrnspergerSubodh S Deshmukh (2 patents)Eric C EhrnspergerMahmoud Mirmehrabi (1 patent)Eric C EhrnspergerWendy Ann Dulin (1 patent)Eric C EhrnspergerSyed M Shah (1 patent)Eric C EhrnspergerXu Meng (1 patent)Eric C EhrnspergerKadum A Shareffi (0 patent)Eric C EhrnspergerEric C Ehrnsperger (12 patents)Syed Muzafar ShahSyed Muzafar Shah (93 patents)Christopher Richard DiorioChristopher Richard Diorio (21 patents)Jonathan Marc CohenJonathan Marc Cohen (10 patents)Kadum A Al ShareffiKadum A Al Shareffi (8 patents)Xu MengXu Meng (6 patents)Mahdi Bakir FawziMahdi Bakir Fawzi (32 patents)Kadum A AliKadum A Ali (8 patents)Panolil C RaveendranathPanolil C Raveendranath (35 patents)Subodh S DeshmukhSubodh S Deshmukh (8 patents)Mahmoud MirmehrabiMahmoud Mirmehrabi (9 patents)Wendy Ann DulinWendy Ann Dulin (5 patents)Syed M ShahSyed M Shah (1 patent)Xu MengXu Meng (1 patent)Kadum A ShareffiKadum A Shareffi (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Wyeth (9 from 1,309 patents)

2. Solvay Pharmaceuticals, B.v. (3 from 67 patents)


12 patents:

1. 10507206 - Oral formulations and lipophilic salts of methylnaltrexone

2. 10376505 - Oral formulations and lipophilic salts of methylnaltrexone

3. 10307417 - Oral formulations and lipophilic salts of methylnaltrexone

4. 9314461 - Oral formulations and lipophilic salts of methylnaltrexone

5. 8956651 - Oral formulations and lipophilic salts of methylnal trexone

6. 8524276 - Oral formulations and lipophilic salts of methylnaltrexone

7. 7771744 - Bazedoxifene acetate formulations

8. 7709024 - Sustained-release formulation and uses thereof

9. 7687520 - Serotonin and norepinephrine reuptake inhibitors and uses thereof

10. 7615551 - Salicylate and gentisate salts of a piperazine compound

11. 7595310 - Glucuronate salt of a piperazine compound

12. 7595340 - Serotonin and norepinephrine reuptake inhibitor and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/31/2025
Loading…